|
MINA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
<1E-12 |
| Normal-vs-Stage3 |
1.77279968482935E-10 |
| Normal-vs-Stage4 |
6.28090024434869E-10 |
| Stage1-vs-Stage2 |
4.850600E-01 |
| Stage1-vs-Stage3 |
1.170480E-02 |
| Stage1-vs-Stage4 |
1.113560E-01 |
| Stage2-vs-Stage3 |
9.480500E-03 |
| Stage2-vs-Stage4 |
2.153700E-02 |
| Stage3-vs-Stage4 |
9.254400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
1.62447832963153E-12 |
| Normal-vs-Asian |
3.64880000000012E-05 |
| Caucasian-vs-AfricanAmerican |
5.383000E-01 |
| Caucasian-vs-Asian |
8.506000E-02 |
| AfricanAmerican-vs-Asian |
1.607560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.33226762955019E-15 |
| Male-vs-Female |
4.6795000000488E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.02140518265514E-14 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
1.62447832963153E-12 |
| Normal-vs-Extreme_Obese |
7.55170000000804E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.128310E-02 |
| Normal_Weight-vs-Obese |
4.657600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.727800E-01 |
| Extreme_Weight-vs-Obese |
2.249700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.769800E-01 |
| Obese-vs-Extreme_Obese |
3.984800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.249700E-04 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
<1E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.106100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.482800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.995700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.306000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.783120E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.093710E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.62447832963153E-12 |
| Normal-VS-KIRP CIMP |
3.359600E-03 |
| Normal-VS-Unclassified PRCC |
1.62436730732907E-12 |
| Type1 PRCC-VS-Type2 PRCC |
3.420000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.11299969240974E-10 |
| Type1 PRCC-VS-Unclassified PRCC |
7.862000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.166300E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
7.368600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.57469999999749E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
4.8567999999527E-07 |
| Normal-vs-N2 |
5.73869999964671E-07 |
| N0-vs-N1 |
3.92240000000044E-05 |
| N0-vs-N2 |
4.184400E-01 |
| N1-vs-N2 |
1.678370E-01 |
|
|
